Autoclaving of Poloxamer 407 hydrogel and its use as a drug delivery vehicle

被引:25
作者
Beard, Mary Catherine [1 ]
Cobb, Leah H. [1 ]
Grant, Christine S. [1 ]
Varadarajan, Anandavalli [2 ]
Henry, Taylor [2 ]
Swanson, Elizabeth A. [3 ]
Kundu, Santanu [2 ]
Priddy, Lauren B. [1 ]
机构
[1] Mississippi State Univ, Dept Agr & Biol Engn, Starkville, MS USA
[2] Mississippi State Univ, Dave C Swalm Sch Chem Engn, Starkville, MS USA
[3] Mississippi State Univ, Coll Vet Med, Dept Clin Sci, Starkville, MS USA
关键词
autoclave; drug delivery; hydrogel; Poloxamer; 407; sterilization; RHEOLOGICAL CHARACTERIZATION; CONTROLLED-RELEASE; IN-VITRO; SUSCEPTIBILITY; LIDOCAINE; P407; GEL;
D O I
10.1002/jbm.b.34703
中图分类号
R318 [生物医学工程];
学科分类号
0831 ;
摘要
With antibiotic-resistant bacteria becoming increasingly prevalent, biomaterials capable of targeted, in situ drug delivery are urgently needed. The synthetic polymer Poloxamer 407 (P407) is of particular interest due to its thermoreversible gelation. Clinical use of P407 typically involves sterilization via autoclaving, but the effects of these extreme environmental conditions on hydrogel water content, rheological properties and efficacy as a drug delivery vehicle remain unknown. The aim of this study was to investigate the effects of autoclaving on the properties of P407 hydrogel. Autoclaving reduced hydrogel water content due to evaporation, thus increasing the polymer weight fraction of the hydrogels. In contrast, except for a reduction in gelation temperature following autoclaving, autoclaved hydrogels had similar rheological properties as nonautoclaved hydrogels. In vitro, autoclaving did not hinder the hydrogel's efficacy as a carrier for vancomycin antibiotic, and P407 (with and without vancomycin) had a bactericidal effect on planktonicStaphylococcus aureus. An in vivo pilot study using P407 to deliver bacteriophage highlighted the need for additional understanding of the functionality of the hydrogel for surgical applications. In conclusion, P407 hydrogel water content and gelation temperature were reduced by autoclave sterilization, while other rheological properties and the efficacy of the biomaterial as a delivery vehicle for vancomycin in vitro were unaffected.
引用
收藏
页码:338 / 347
页数:10
相关论文
共 27 条
  • [1] Poly(ethylene oxide) poly(propylene oxide) block copolymer surfactants
    Alexandridis, P
    [J]. CURRENT OPINION IN COLLOID & INTERFACE SCIENCE, 1997, 2 (05) : 478 - 489
  • [2] Bansal Monika, 2018, J Oral Biol Craniofac Res, V8, P126, DOI 10.1016/j.jobcr.2017.12.005
  • [3] BAUER AW, 1966, AM J CLIN PATHOL, V45, P493
  • [4] Temporary coronary artery occlusion during off-pump coronary artery bypass grafting with the new poloxamer P407 does not cause endothelial dysfunction in epicardial coronary arteries
    Bouchot, Olivier
    Aubin, Marie-Claude
    Carrier, Michel
    Cohn, William E.
    Perrault, Louis P.
    [J]. JOURNAL OF THORACIC AND CARDIOVASCULAR SURGERY, 2006, 132 (05) : 1144 - 1149
  • [5] Study of the gelation process of polyethylene oxide(a) polypropylene oxide(b) polyethylene oxide(a) copolymer (Poloxamer 407) aqueous solutions
    Cabana, A
    AitKadi, A
    Juhasz, J
    [J]. JOURNAL OF COLLOID AND INTERFACE SCIENCE, 1997, 190 (02) : 307 - 312
  • [6] Preparation and evaluation of a chitosan salt-poloxamer 407 based matrix for buccal drug delivery
    Cafaggi, S
    Leardi, R
    Parodi, B
    Caviglioli, G
    Russo, E
    Bignardi, G
    [J]. JOURNAL OF CONTROLLED RELEASE, 2005, 102 (01) : 159 - 169
  • [7] Ci LQ, 2017, ACTA PHARM SIN B, V7, P593, DOI [10.1016/j.apsh.2017.03.002, 10.1016/j.apsb.2017.03.002]
  • [8] CRISPR-Cas9 modified bacteriophage for treatment of Staphylococcus aureus induced osteomyelitis and soft tissue infection
    Cobb, Leah H.
    Park, JooYoun
    Swanson, Elizabeth A.
    Beard, Mary Catherine
    McCabe, Emily M.
    Rourke, Anna S.
    Seo, Keun Seok
    Olivier, Alicia K.
    Priddy, Lauren B.
    [J]. PLOS ONE, 2019, 14 (11):
  • [9] In vitro evaluation of pluronic F127-based controlled-release ocular delivery systems for pilocarpine
    Desai, SD
    Blanchard, J
    [J]. JOURNAL OF PHARMACEUTICAL SCIENCES, 1998, 87 (02) : 226 - 230
  • [10] Escobar-Chávez JJ, 2006, J PHARM PHARM SCI, V9, P339